骨形态发生蛋白 7 在骨折不愈合中的应用。
The use of bone morphogenetic protein 7 in fracture non-unions.
机构信息
Department of Trauma and Orthopaedics, St. Vincent's University Hospital, Elm Park, Dublin, Ireland.
出版信息
Orthop Surg. 2011 Feb;3(1):40-4. doi: 10.1111/j.1757-7861.2010.00119.x.
Abstract
OBJECTIVE
To assess the rate of clinical and radiological union with the use of bone morphogenetic protein 7 (BMP-7) in a range of fractures.
METHODS
This case series retrospectively reviews a series of 16 fracture non-unions in 13 patients. These patients were treated with the commercially available BMP-7. Time to radiological and clinical union was assessed by serial out-patient follow-up.
RESULTS
At nine months post-surgery in which BMP-7 was added, 12 of 16 non-unions had achieved clinical and radiographic union. Three patients required repeat grafting. The mean time to union was 5.1 ± 1.6 months after the application of BMP-7.
CONCLUSION
The use of the osteo-inductive agent, BMP-7 results in good clinical and radiological outcomes which are not restricted to tibial non-unions.
摘要
目的
评估在多种骨折中使用骨形成蛋白 7（BMP-7）的临床和影像学愈合率。
方法
本病例系列回顾性分析了 13 名患者的 16 例骨折不愈合。这些患者使用市售的 BMP-7 进行治疗。通过门诊随访评估影像学和临床愈合的时间。
结果
在 BMP-7 加入后的 9 个月，16 例骨折不愈合中有 12 例达到了临床和影像学愈合。3 名患者需要再次植骨。BMP-7 应用后，平均愈合时间为 5.1±1.6 个月。
结论
使用成骨诱导剂 BMP-7 可获得良好的临床和影像学结果，不仅限于胫骨骨折不愈合。
相似文献
1
The use of bone morphogenetic protein 7 in fracture non-unions.
Orthop Surg. 2011 Feb;3(1):40-4. doi: 10.1111/j.1757-7861.2010.00119.x.
2
The use of bone morphogenic protein-7 (OP-1) in the management of resistant non-unions in the upper and lower limb.
Injury. 2012 Jul;43(7):1135-40. doi: 10.1016/j.injury.2012.03.007. Epub 2012 Mar 30.
3
Application of recombinant BMP-7 on persistent upper and lower limb non-unions.
Injury. 2005 Nov;36 Suppl 4:S51-9. doi: 10.1016/j.injury.2005.10.010.
4
Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
Injury. 2008 Dec;39(12):1391-402. doi: 10.1016/j.injury.2008.08.011. Epub 2008 Nov 22.
5
BMP-7 versus BMP-2 for the treatment of long bone nonunion.
Orthopedics. 2014 Dec;37(12):e1049-57. doi: 10.3928/01477447-20141124-50.
6
Application of BMP-7 to tibial non-unions: a 3-year multicenter experience.
Injury. 2008 Sep;39 Suppl 2:S83-90. doi: 10.1016/S0020-1383(08)70019-6.
7
Upper limb non-unions treated with BMP-7: efficacy and clinical results.
Injury. 2016 Dec;47 Suppl 6:S33-S39. doi: 10.1016/S0020-1383(16)30837-3.
8
Application of bone morphogenetic proteins to femoral non-unions: a 4-year multicentre experience.
Injury. 2009 Dec;40 Suppl 3:S54-61. doi: 10.1016/S0020-1383(09)70013-0.
9
Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
Orthop Traumatol Surg Res. 2018 Dec;104(8):1241-1248. doi: 10.1016/j.otsr.2018.08.008. Epub 2018 Oct 4.
10
Clinical application of BMP 7 in long bone non-unions.
Arch Orthop Trauma Surg. 2010 Jan;130(1):71-6. doi: 10.1007/s00402-009-0982-x. Epub 2009 Nov 3.
引用本文的文献
1
Bone Morphogenic Protein for Upper Extremity Fractures: A Systematic Review.
Hand (N Y). 2023 Jan;18(1):80-88. doi: 10.1177/1558944721990805. Epub 2021 Mar 31.
2
Assessment of the Defatting Efficacy of Mechanical and Chemical Treatment for Allograft Cancellous Bone and Its Effects on Biomechanics Properties of Bone.
Orthop Surg. 2020 Apr;12(2):617-630. doi: 10.1111/os.12639. Epub 2020 Mar 18.
3
Clinical application of bone morphogenetic proteins for bone healing: a systematic review.
Int Orthop. 2017 Jun;41(6):1073-1083. doi: 10.1007/s00264-017-3471-9. Epub 2017 Apr 19.
4
Current application of β-tricalcium phosphate composites in orthopaedics.
Orthop Surg. 2012 Aug;4(3):139-44. doi: 10.1111/j.1757-7861.2012.00189.x.
5
Studies of bone morphogenetic protein-based surgical repair.
Adv Drug Deliv Rev. 2012 Sep;64(12):1277-91. doi: 10.1016/j.addr.2012.03.014. Epub 2012 Apr 2.
6
Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds.
Biotechnol Bioeng. 2011 Nov;108(11):2727-35. doi: 10.1002/bit.23227. Epub 2011 Jun 21.
本文引用的文献
1
Enhancement of bone formation by BMP-7 transduced MSCs on biomimetic nano-hydroxyapatite/polyamide composite scaffolds in repair of mandibular defects.
J Biomed Mater Res A. 2010 Dec 15;95(4):973-81. doi: 10.1002/jbm.a.32926. Epub 2010 Sep 15.
2
Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft.
Orthop Clin North Am. 2010 Jan;41(1):75-84; table of contents. doi: 10.1016/j.ocl.2009.07.006.
3
A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7.
Int Orthop. 2009 Oct;33(5):1407-14. doi: 10.1007/s00264-008-0709-6. Epub 2008 Dec 4.
4
Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.
Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv. doi: 10.3310/hta11300.
5
Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur.
J Bone Joint Surg Am. 2006 Jul;88(7):1510-23. doi: 10.2106/JBJS.E.01136.
6
Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions.
Bull Hosp Jt Dis. 2005;63(1-2):20-3.
7
Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow.
J Orthop Res. 2003 May;21(3):521-8. doi: 10.1016/S0736-0266(02)00205-X.
8
Bone formation by BMP-7-transduced human gingival keratinocytes.
J Dent Res. 2003 Apr;82(4):293-7. doi: 10.1177/154405910308200410.
9
Healing of fresh tibial fractures with OP-1. A preliminary report.
Acta Biomed. 2002;73(1-2):27-33.
10
Mechanism for the action of bone morphogenetic proteins and regulation of their activity.
Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S10-5. doi: 10.1097/00007632-200208151-00004.
Zotero 插件